Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL314138

COc1cccc(-c2nnc3n2-c2cc(Cl)ccc2NC[C@H]3C)c1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
P2RX7 Q99572 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GLA P06280 1/20 0.36
BRD4 O60885 1/20 0.36
GPR6 P46095 1/20 0.35
HSD17B3 P37058 1/20 0.35
CNR1 P21554 1/20 0.35
NPC1 O15118 2/20 0.35
TP53 P04637 1/20 0.35
SLC16A3 O15427 3/20 0.35
SLC16A1 P53985 3/20 0.35
MCTS1 Q9ULC4 2/20 0.35
WNK1 Q9H4A3 1/20 0.35
BACE1 P56817 1/20 0.35
PIN1 Q13526 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL314137 1.00 ALDH1A1 (0.42) ALDH1A1P2RX7SMN1; SMN2GLABRD4
SCHEMBL314787 0.91 ALDH1A1 (0.45) ALDH1A1P2RX7GLACNR1
SCHEMBL315855 0.91 ALDH1A1 (0.45) ALDH1A1P2RX7GLACNR1
SCHEMBL315856 0.91 ALDH1A1 (0.45) ALDH1A1P2RX7GLACNR1
SCHEMBL314088 0.84 ALDH1A1 (0.45) ALDH1A1P2RX7GLAHSD17B3CNR1
SCHEMBL314087 0.84 ALDH1A1 (0.45) ALDH1A1P2RX7GLAHSD17B3CNR1
SCHEMBL314086 0.84 ALDH1A1 (0.45) ALDH1A1P2RX7GLAHSD17B3CNR1
SCHEMBL313658 0.83 HSD11B1 (0.41) ALDH1A1SMN1; SMN2GLABRD4CNR1
SCHEMBL313656 0.83 HSD11B1 (0.41) ALDH1A1SMN1; SMN2GLABRD4CNR1
SCHEMBL313657 0.83 HSD11B1 (0.41) ALDH1A1SMN1; SMN2GLABRD4CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP claimed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US claimed
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US disclosed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP disclosed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306042-A1 Triazole Derivatives TGFBR1, TGFBR2, SMAD3 ALDH1A1 2295/4885P2RX7 3204/4885SMN1; SMN2 4841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.